Aegis Capital is transferring coverage on CytRx Corp. (Nasdaq: CYTR) today. The firm maintains a Buy rating and lowers ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE